UTHR logo

United Therapeutics (UTHR) Cash from investing

annual CFI:

$417.20M+$1.14B(+157.98%)
December 31, 2024

Summary

  • As of today (May 29, 2025), UTHR annual cash flow from investing activities is $417.20 million, with the most recent change of +$1.14 billion (+157.98%) on December 31, 2024.
  • During the last 3 years, UTHR annual CFI has risen by +$904.10 million (+185.68%).
  • UTHR annual CFI is now -17.16% below its all-time high of $503.60 million, reached on December 31, 2015.

Performance

UTHR Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRcash flow metrics

quarterly CFI:

-$164.70M-$41.50M(-33.69%)
March 31, 2025

Summary

  • As of today (May 29, 2025), UTHR quarterly cash flow from investing activities is -$164.70 million, with the most recent change of -$41.50 million (-33.69%) on March 31, 2025.
  • Over the past year, UTHR quarterly CFI has dropped by -$900.00 million (-122.40%).
  • UTHR quarterly CFI is now -122.40% below its all-time high of $735.30 million, reached on March 31, 2024.

Performance

UTHR quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRcash flow metrics

TTM CFI:

-$482.80M-$900.00M(-215.72%)
March 31, 2025

Summary

  • As of today (May 29, 2025), UTHR TTM cash flow from investing activities is -$482.80 million, with the most recent change of -$900.00 million (-215.72%) on March 31, 2025.
  • Over the past year, UTHR TTM CFI has dropped by -$719.60 million (-303.89%).
  • UTHR TTM CFI is now -182.88% below its all-time high of $582.50 million, reached on September 30, 2024.

Performance

UTHR TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

UTHR Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+158.0%-122.4%-303.9%
3 y3 years+185.7%+54.1%+42.5%
5 y5 years+224.4%-496.7%-59.5%

UTHR Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+151.4%-122.4%+54.1%-182.9%+49.7%
5 y5-yearat high+151.4%-122.4%+56.1%-182.9%+49.7%
alltimeall time-17.2%+149.9%-122.4%+56.1%-182.9%+53.0%

UTHR Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$164.70M(+33.7%)
-$482.80M(-215.7%)
Dec 2024
$417.20M(-158.0%)
-$123.20M(+7.2%)
$417.20M(-28.4%)
Sep 2024
-
-$114.90M(+43.6%)
$582.50M(+51.7%)
Jun 2024
-
-$80.00M(-110.9%)
$384.00M(+62.2%)
Mar 2024
-
$735.30M(+1646.6%)
$236.80M(-132.9%)
Dec 2023
-$719.60M(-11.3%)
$42.10M(-113.4%)
-$719.60M(-24.3%)
Sep 2023
-
-$313.40M(+37.9%)
-$951.00M(+30.0%)
Jun 2023
-
-$227.20M(+2.8%)
-$731.60M(+8.6%)
Mar 2023
-
-$221.10M(+16.8%)
-$673.40M(-17.0%)
Dec 2022
-$811.50M(+66.7%)
-$189.30M(+101.4%)
-$811.50M(-0.8%)
Sep 2022
-
-$94.00M(-44.4%)
-$818.00M(-14.8%)
Jun 2022
-
-$169.00M(-53.0%)
-$959.90M(+14.3%)
Mar 2022
-
-$359.20M(+83.5%)
-$839.80M(+72.5%)
Dec 2021
-$486.90M(-34.1%)
-$195.80M(-17.0%)
-$486.90M(+37.2%)
Sep 2021
-
-$235.90M(+382.4%)
-$354.90M(-9.2%)
Jun 2021
-
-$48.90M(+676.2%)
-$390.70M(-45.5%)
Mar 2021
-
-$6.30M(-90.1%)
-$717.20M(-2.9%)
Dec 2020
-$738.50M(+120.2%)
-$63.80M(-76.5%)
-$738.50M(+21.4%)
Sep 2020
-
-$271.70M(-27.6%)
-$608.50M(-4.2%)
Jun 2020
-
-$375.40M(+1260.1%)
-$635.50M(+109.9%)
Mar 2020
-
-$27.60M(-141.7%)
-$302.70M(-9.7%)
Dec 2019
-$335.40M(-59.1%)
$66.20M(-122.2%)
-$335.40M(-29.2%)
Sep 2019
-
-$298.70M(+601.2%)
-$473.80M(-6.2%)
Jun 2019
-
-$42.60M(-29.4%)
-$505.00M(-38.6%)
Mar 2019
-
-$60.30M(-16.5%)
-$822.20M(+0.2%)
Dec 2018
-$820.60M(-1.8%)
-$72.20M(-78.1%)
-$820.60M(-20.1%)
Sep 2018
-
-$329.90M(-8.3%)
-$1.03B(+14.5%)
Jun 2018
-
-$359.80M(+512.9%)
-$897.10M(+23.1%)
Mar 2018
-
-$58.70M(-78.9%)
-$728.70M(-12.8%)
Dec 2017
-$835.60M(-1830.0%)
-$278.40M(+39.1%)
-$835.60M(+52.3%)
Sep 2017
-
-$200.20M(+4.6%)
-$548.70M(+67.1%)
Jun 2017
-
-$191.40M(+15.6%)
-$328.40M(+154.0%)
Mar 2017
-
-$165.60M(-2048.2%)
-$129.30M(-367.7%)
Dec 2016
$48.30M(-90.4%)
$8.50M(-57.7%)
$48.30M(-49.8%)
Sep 2016
-
$20.10M(+161.0%)
$96.30M(-77.3%)
Jun 2016
-
$7.70M(-35.8%)
$423.80M(-5.2%)
Mar 2016
-
$12.00M(-78.8%)
$447.20M(-11.2%)
Dec 2015
$503.60M(+48.8%)
$56.50M(-83.7%)
$503.60M(+0.9%)
Sep 2015
-
$347.60M(+1017.7%)
$499.09M(+100.1%)
Jun 2015
-
$31.10M(-54.5%)
$249.44M(-17.0%)
Mar 2015
-
$68.40M(+31.6%)
$300.52M(-11.2%)
Dec 2014
$338.50M(-214.8%)
$51.99M(-46.9%)
$338.50M(+160.1%)
Sep 2014
-
$97.95M(+19.2%)
$130.15M(-190.6%)
Jun 2014
-
$82.18M(-22.7%)
-$143.62M(-27.9%)
Mar 2014
-
$106.38M(-168.0%)
-$199.23M(-32.5%)
Dec 2013
-$294.97M(+80.6%)
-$156.35M(-11.1%)
-$294.97M(-2.8%)
Sep 2013
-
-$175.82M(-761.8%)
-$303.32M(+279.7%)
Jun 2013
-
$26.57M(+149.8%)
-$79.88M(-25.2%)
Mar 2013
-
$10.63M(-106.5%)
-$106.74M(-34.7%)
Dec 2012
-$163.36M(+34.6%)
-$164.70M(-445.9%)
-$163.36M(-1032.9%)
Sep 2012
-
$47.61M(<-9900.0%)
$17.51M(-119.9%)
Jun 2012
-
-$287.00K(-99.4%)
-$88.06M(-33.3%)
Mar 2012
-
-$45.99M(-384.3%)
-$131.99M(+8.8%)
DateAnnualQuarterlyTTM
Dec 2011
-$121.33M(-42.0%)
$16.18M(-127.9%)
-$121.33M(-39.6%)
Sep 2011
-
-$57.96M(+31.1%)
-$200.82M(-39.9%)
Jun 2011
-
-$44.21M(+25.1%)
-$333.94M(+32.1%)
Mar 2011
-
-$35.34M(-44.2%)
-$252.80M(+20.8%)
Dec 2010
-$209.24M(+28.7%)
-$63.31M(-66.9%)
-$209.24M(-2.2%)
Sep 2010
-
-$191.08M(-617.4%)
-$213.96M(+278.8%)
Jun 2010
-
$36.93M(+348.9%)
-$56.48M(-52.5%)
Mar 2010
-
$8.23M(-112.1%)
-$118.82M(-26.9%)
Dec 2009
-$162.62M(-5.7%)
-$68.03M(+102.5%)
-$162.62M(+59.9%)
Sep 2009
-
-$33.60M(+32.2%)
-$101.72M(-18.9%)
Jun 2009
-
-$25.42M(-28.5%)
-$125.39M(-36.8%)
Mar 2009
-
-$35.57M(+398.9%)
-$198.52M(+15.1%)
Dec 2008
-$172.48M(+694.6%)
-$7.13M(-87.6%)
-$172.48M(+18.6%)
Sep 2008
-
-$57.28M(-41.9%)
-$145.46M(+8.3%)
Jun 2008
-
-$98.54M(+934.0%)
-$134.34M(+164.2%)
Mar 2008
-
-$9.53M(-147.9%)
-$50.84M(+134.2%)
Dec 2007
-$21.71M(-78.6%)
$19.89M(-143.1%)
-$21.71M(-77.7%)
Sep 2007
-
-$46.16M(+206.9%)
-$97.19M(+74.0%)
Jun 2007
-
-$15.04M(-176.7%)
-$55.85M(-30.6%)
Mar 2007
-
$19.61M(-135.3%)
-$80.45M(-20.8%)
Dec 2006
-$101.63M(+43.7%)
-$55.60M(+1052.7%)
-$101.63M(+73.1%)
Sep 2006
-
-$4.82M(-87.8%)
-$58.71M(-1.6%)
Jun 2006
-
-$39.63M(+2416.5%)
-$59.66M(-8.1%)
Mar 2006
-
-$1.57M(-87.6%)
-$64.93M(-8.2%)
Dec 2005
-$70.74M(+449.7%)
-$12.68M(+119.6%)
-$70.74M(+4.8%)
Sep 2005
-
-$5.77M(-87.1%)
-$67.48M(+8.0%)
Jun 2005
-
-$44.90M(+507.9%)
-$62.50M(+212.8%)
Mar 2005
-
-$7.39M(-21.6%)
-$19.98M(+55.2%)
Dec 2004
-$12.87M(-72.9%)
-$9.42M(+1089.1%)
-$12.87M(+48.6%)
Sep 2004
-
-$792.00K(-66.8%)
-$8.66M(-52.0%)
Jun 2004
-
-$2.38M(+760.3%)
-$18.05M(+7.3%)
Mar 2004
-
-$277.00K(-94.7%)
-$16.83M(-64.6%)
Dec 2003
-$47.54M(-139.5%)
-$5.21M(-48.8%)
-$47.54M(-11.6%)
Sep 2003
-
-$10.18M(+776.2%)
-$53.77M(-166.2%)
Jun 2003
-
-$1.16M(-96.2%)
$81.18M(-3.9%)
Mar 2003
-
-$30.98M(+170.7%)
$84.48M(-29.8%)
Dec 2002
$120.36M(-189.3%)
-$11.45M(-109.2%)
$120.36M(+56.1%)
Sep 2002
-
$124.78M(+5744.3%)
$77.10M(-168.7%)
Jun 2002
-
$2.13M(-56.4%)
-$112.15M(-8.0%)
Mar 2002
-
$4.89M(-108.9%)
-$121.96M(-9.5%)
Dec 2001
-$134.78M(-1983.2%)
-$54.71M(-15.2%)
-$134.78M(+50.9%)
Sep 2001
-
-$64.48M(+740.4%)
-$89.31M(+258.7%)
Jun 2001
-
-$7.67M(-3.2%)
-$24.89M(+43.3%)
Mar 2001
-
-$7.93M(-14.1%)
-$17.38M(-342.8%)
Dec 2000
$7.16M(-129.7%)
-$9.23M(>+9900.0%)
$7.16M(-80.7%)
Sep 2000
-
-$65.00K(-58.2%)
$37.09M(+4.6%)
Jun 2000
-
-$155.60K(-100.9%)
$35.45M(-303.8%)
Mar 2000
-
$16.61M(-19.8%)
-$17.39M(-27.8%)
Dec 1999
-$24.10M(+109.6%)
$20.70M(-1317.6%)
-$24.10M(-46.2%)
Sep 1999
-
-$1.70M(-96.8%)
-$44.80M(+3.9%)
Jun 1999
-
-$53.00M(-635.4%)
-$43.10M(-535.4%)
Mar 1999
-
$9.90M
$9.90M
Dec 1998
-$11.50M
-
-

FAQ

  • What is United Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for United Therapeutics?
  • What is United Therapeutics annual CFI year-on-year change?
  • What is United Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for United Therapeutics?
  • What is United Therapeutics quarterly CFI year-on-year change?
  • What is United Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for United Therapeutics?
  • What is United Therapeutics TTM CFI year-on-year change?

What is United Therapeutics annual cash flow from investing activities?

The current annual CFI of UTHR is $417.20M

What is the all time high annual CFI for United Therapeutics?

United Therapeutics all-time high annual cash flow from investing activities is $503.60M

What is United Therapeutics annual CFI year-on-year change?

Over the past year, UTHR annual cash flow from investing activities has changed by +$1.14B (+157.98%)

What is United Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of UTHR is -$164.70M

What is the all time high quarterly CFI for United Therapeutics?

United Therapeutics all-time high quarterly cash flow from investing activities is $735.30M

What is United Therapeutics quarterly CFI year-on-year change?

Over the past year, UTHR quarterly cash flow from investing activities has changed by -$900.00M (-122.40%)

What is United Therapeutics TTM cash flow from investing activities?

The current TTM CFI of UTHR is -$482.80M

What is the all time high TTM CFI for United Therapeutics?

United Therapeutics all-time high TTM cash flow from investing activities is $582.50M

What is United Therapeutics TTM CFI year-on-year change?

Over the past year, UTHR TTM cash flow from investing activities has changed by -$719.60M (-303.89%)
On this page